Fierce Pharma10d
Novartis plans 427 layoffs as looming Entresto patent cliff sparks marketing refresh
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
pharmaphorum1d
Novartis bid to block generic Entresto in US suffers setback
MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a legal complaint from Novartis seeking to block its launch. In August, a Delaware ...
Hosted on MSN2mon
FDA approves drug application for Lupin’s heart failure therapy
has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan tablets are the generic equivalent of ...
pharmaphorum2d
Judge rebuffs Novartis bid to block generic Entresto
MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...